DCGI gives nod to Bharat Biotech to conduct phase I & II Human clinical trials to develop indigenous vaccine for COVID-19 – ANI News
New Delhi [India], June 30 (ANI): The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human clinical trials t…
